Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eren Aytekin, Ph.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Polat HK, Kurt N, Aytekin E, Bozdag Pehlivan S, Çalis S. Novel Drug Delivery Systems to Improve the Treatment of Keratitis. J Ocul Pharmacol Ther. 2022 Jul-Aug; 38(6):376-395. PMID: 35763406.
    Citations:    Fields:    Translation:Animals
  2. Polat HK, Kurt N, Aytekin E, Akdag Çayli Y, Bozdag Pehlivan S, Çalis S. Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation. J Ocul Pharmacol Ther. 2022 Jul-Aug; 38(6):412-423. PMID: 35675672.
    Citations: 2     Fields:    Translation:Humans
  3. Polat HK, Bozdag Pehlivan S, Özkul C, Çalamak S, Öztürk N, Aytekin E, Firat A, Ulubayram K, Kocabeyoglu S, Irkeç M, Çalis S. Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation. Int J Pharm. 2020 Jul 30; 585:119552. PMID: 32569814.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  4. Aytekin E, Öztürk N, Vural I, Polat HK, Çakmak HB, Çalis S, Pehlivan SB. Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment. J Control Release. 2020 08 10; 324:238-249. PMID: 32413453.
    Citations: 2     Fields:    Translation:Animals
  5. Timur SS, Sahin A, Aytekin E, Öztürk N, Polat KH, Tezel N, Gürsoy RN, Çalis S. Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections. Pharm Dev Technol. 2018 Mar; 23(3):301-310. PMID: 28503983.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  6. Yildiz S, Aytekin E, Yavuz B, Bozdag Pehlivan S, Vural I, Ünlü N. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules. Pharm Dev Technol. 2018 Jun; 23(5):488-495. PMID: 28368673.
    Citations: 2     Fields:    Translation:HumansCells
  7. Yildiz S, Aytekin E, Yavuz B, Bozdag Pehlivan S, Ünlü N. Formulation studies for mirtazapine orally disintegrating tablets. Drug Dev Ind Pharm. 2016; 42(6):1008-17. PMID: 26530146.
    Citations: 1     Fields:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Aytekin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (54)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.